[Form 4] Kenvue Inc. Insider Trading Activity
On 2 July 2025, Auburn National Bancorporation (AUBN) director David E. Housel filed a Form 4 reporting two DRIP/optional cash purchases of the company鈥檚 common stock.
- 38 shares acquired at $24.6912
- 17 shares acquired at $23.2233
Housel鈥檚 direct holdings rose from an estimated 8,476 to 8,531 shares, a 0.6% increase, at a total outlay of roughly $1,338. No derivative securities were involved, and no Rule 10b5-1 plan was indicated.
While insider buying is generally viewed positively, the transaction size鈥�55 shares versus AUBN鈥檚 ~3.6 million shares outstanding鈥攊s immaterial from a valuation or liquidity standpoint. The filing nevertheless provides a nominal signal of continued board-level confidence in the bank.
Il 2 luglio 2025, il direttore di Auburn National Bancorporation (AUBN), David E. Housel, ha presentato un Modulo 4 segnalando due acquisti DRIP/opzionali in contanti di azioni ordinarie della societ脿.
- 38 azioni acquistate a 24,6912 $
- 17 azioni acquistate a 23,2233 $
Le partecipazioni dirette di Housel sono aumentate da circa 8.476 a 8.531 azioni, un incremento dello 0,6%, con una spesa totale di circa 1.338 $. Non sono stati coinvolti strumenti derivati e non 猫 stato indicato alcun piano Rule 10b5-1.
Pur essendo generalmente considerati positivi, gli acquisti da parte degli insider, la dimensione della transazione鈥�55 azioni rispetto alle circa 3,6 milioni di azioni in circolazione di AUBN鈥攕ono irrilevanti dal punto di vista della valutazione o della liquidit脿. Tuttavia, la segnalazione fornisce un segnale nominale di fiducia continua a livello di consiglio nella banca.
El 2 de julio de 2025, el director de Auburn National Bancorporation (AUBN), David E. Housel, present贸 un Formulario 4 informando sobre dos compras opcionales en efectivo/DRIP de acciones comunes de la empresa.
- 38 acciones adquiridas a $24.6912
- 17 acciones adquiridas a $23.2233
Las participaciones directas de Housel aumentaron de aproximadamente 8,476 a 8,531 acciones, un incremento del 0.6%, con un desembolso total de aproximadamente $1,338. No se involucraron valores derivados ni se indic贸 ning煤n plan bajo la Regla 10b5-1.
Aunque las compras internas suelen verse de manera positiva, el tama帽o de la transacci贸n鈥�55 acciones frente a las aproximadamente 3.6 millones de acciones en circulaci贸n de AUBN鈥攅s insignificante desde el punto de vista de la valoraci贸n o la liquidez. Sin embargo, la presentaci贸n proporciona una se帽al nominal de confianza continua a nivel de junta en el banco.
2025雲� 7鞗� 2鞚�, Auburn National Bancorporation(AUBN) 鞚挫偓 David E. Housel臧� 須岇偓 氤错喌欤检棎 雽�頃� 霊� 瓯挫潣 DRIP/靹犿儩鞝� 順勱笀 毵れ垬毳� 氤搓碃頃橂姅 Form 4毳� 鞝滌稖頄堨姷雼堧嫟.
- 38欤茧ゼ $24.6912鞐� 毵れ垬
- 17欤茧ゼ $23.2233鞐� 毵れ垬
Housel鞚� 歆侅爲 氤挫湢 欤检嫕鞚� 鞎� 8,476欤检棎靹� 8,531欤�搿� 0.6% 歃濌皜頄堨溂氅�, 齑� 歆�於滌暋鞚� 鞎� $1,338鞛呺媹雼�. 韺岇儩歃濌秾鞚� 韽暔霅橃 鞎婌晿鞙茧┌, Rule 10b5-1 瓿勴殟霃� 氇呾嫓霅橃 鞎婌晿鞀惦媹雼�.
雮措秬鞛� 毵れ垬電� 鞚茧皹鞝侅溂搿� 旮嶌爼鞝侅溂搿� 韽夑皜霅橃毵�, 鞚措矆 瓯半灅 攴滊鈥�55欤缄皜 AUBN鞚� 鞎� 360毵� 欤� 氚滍枆欤检嫕鞐� 牍勴暣鈥旊姅 臧�旃� 韽夑皜雮� 鞙犽彊靹� 旄‰┐鞐愳劀 氙鸽頃╇媹雼�. 攴鸽熂鞐愲弰 攵堦惮頃橁碃 鞚措矆 鞁犼碃電� 鞚�頄� 鞚挫偓須� 彀洂鞚� 歆�靻嶌爜鞚� 鞁犽毳� 雮橅儉雮措姅 氇呺靸侅潣 鞁犿樃毳� 鞝滉车頃╇媹雼�.
Le 2 juillet 2025, David E. Housel, administrateur de Auburn National Bancorporation (AUBN), a d茅pos茅 un formulaire 4 signalant deux achats DRIP/optionnels en esp猫ces d鈥檃ctions ordinaires de la soci茅t茅.
- 38 actions acquises 脿 24,6912 $
- 17 actions acquises 脿 23,2233 $
Les participations directes de Housel sont pass茅es d鈥檈nviron 8 476 脿 8 531 actions, soit une augmentation de 0,6 %, pour un co没t total d鈥檈nviron 1 338 $. Aucun instrument d茅riv茅 n鈥檃 茅t茅 impliqu茅, et aucun plan Rule 10b5-1 n鈥檃 茅t茅 indiqu茅.
Bien que les achats d鈥檌niti茅s soient g茅n茅ralement per莽us positivement, la taille de la transaction鈥�55 actions par rapport aux quelque 3,6 millions d鈥檃ctions en circulation d鈥橝UBN鈥攅st n茅gligeable en termes d鈥櫭﹙aluation ou de liquidit茅. N茅anmoins, ce d茅p么t constitue un signal nominal de confiance continue au niveau du conseil d鈥檃dministration de la banque.
Am 2. Juli 2025 reichte David E. Housel, Direktor der Auburn National Bancorporation (AUBN), ein Formular 4 ein, in dem zwei DRIP-/optionale Bark盲ufe von Stammaktien des Unternehmens gemeldet wurden.
- 38 Aktien zu 24,6912 $ erworben
- 17 Aktien zu 23,2233 $ erworben
Housels direkte Beteiligungen stiegen von gesch盲tzten 8.476 auf 8.531 Aktien, ein Anstieg von 0,6 %, bei einem Gesamtaufwand von etwa 1.338 $. Es waren keine Derivate beteiligt, und es wurde kein Rule-10b5-1-Plan angegeben.
Obwohl Insiderk盲ufe allgemein positiv bewertet werden, ist die Transaktionsgr枚脽e鈥�55 Aktien im Vergleich zu den etwa 3,6 Millionen ausstehenden AUBN-Aktien鈥攁us Bewertungs- oder Liquidit盲tssicht unerheblich. Die Meldung signalisiert dennoch nominal ein anhaltendes Vertrauen auf Vorstandsebene in die Bank.
- Director insider purchase: Even modest buying by a board member can signal incremental confidence in Auburn National Bancorp鈥檚 outlook.
- Immaterial size: The 55-share purchase (<$1.4k) represents an insignificant change in ownership and is unlikely to affect valuation or market perception.
Insights
TL;DR: Tiny insider buy; positive sentiment cue but financially immaterial鈥攕hould not alter investment thesis.
The purchase totals only 55 shares (<$1.4k), suggesting it is a routine DRIP contribution rather than a conviction buy. Insider accumulation can foreshadow favorable fundamentals, yet this scale is far below materiality thresholds. I view the disclosure as neutral: a mild confidence signal offset by negligible impact on share supply, earnings, or book value.
TL;DR: Director participation in DRIP shows alignment but lacks strategic significance.
Board-level ownership aligns director incentives with shareholders, and periodic DRIP participation underscores commitment. However, best-practice governance evaluates aggregate insider flow, not isolated micro-purchases. The filing maintains transparency but offers no red-flag or catalytic insight.
Il 2 luglio 2025, il direttore di Auburn National Bancorporation (AUBN), David E. Housel, ha presentato un Modulo 4 segnalando due acquisti DRIP/opzionali in contanti di azioni ordinarie della societ脿.
- 38 azioni acquistate a 24,6912 $
- 17 azioni acquistate a 23,2233 $
Le partecipazioni dirette di Housel sono aumentate da circa 8.476 a 8.531 azioni, un incremento dello 0,6%, con una spesa totale di circa 1.338 $. Non sono stati coinvolti strumenti derivati e non 猫 stato indicato alcun piano Rule 10b5-1.
Pur essendo generalmente considerati positivi, gli acquisti da parte degli insider, la dimensione della transazione鈥�55 azioni rispetto alle circa 3,6 milioni di azioni in circolazione di AUBN鈥攕ono irrilevanti dal punto di vista della valutazione o della liquidit脿. Tuttavia, la segnalazione fornisce un segnale nominale di fiducia continua a livello di consiglio nella banca.
El 2 de julio de 2025, el director de Auburn National Bancorporation (AUBN), David E. Housel, present贸 un Formulario 4 informando sobre dos compras opcionales en efectivo/DRIP de acciones comunes de la empresa.
- 38 acciones adquiridas a $24.6912
- 17 acciones adquiridas a $23.2233
Las participaciones directas de Housel aumentaron de aproximadamente 8,476 a 8,531 acciones, un incremento del 0.6%, con un desembolso total de aproximadamente $1,338. No se involucraron valores derivados ni se indic贸 ning煤n plan bajo la Regla 10b5-1.
Aunque las compras internas suelen verse de manera positiva, el tama帽o de la transacci贸n鈥�55 acciones frente a las aproximadamente 3.6 millones de acciones en circulaci贸n de AUBN鈥攅s insignificante desde el punto de vista de la valoraci贸n o la liquidez. Sin embargo, la presentaci贸n proporciona una se帽al nominal de confianza continua a nivel de junta en el banco.
2025雲� 7鞗� 2鞚�, Auburn National Bancorporation(AUBN) 鞚挫偓 David E. Housel臧� 須岇偓 氤错喌欤检棎 雽�頃� 霊� 瓯挫潣 DRIP/靹犿儩鞝� 順勱笀 毵れ垬毳� 氤搓碃頃橂姅 Form 4毳� 鞝滌稖頄堨姷雼堧嫟.
- 38欤茧ゼ $24.6912鞐� 毵れ垬
- 17欤茧ゼ $23.2233鞐� 毵れ垬
Housel鞚� 歆侅爲 氤挫湢 欤检嫕鞚� 鞎� 8,476欤检棎靹� 8,531欤�搿� 0.6% 歃濌皜頄堨溂氅�, 齑� 歆�於滌暋鞚� 鞎� $1,338鞛呺媹雼�. 韺岇儩歃濌秾鞚� 韽暔霅橃 鞎婌晿鞙茧┌, Rule 10b5-1 瓿勴殟霃� 氇呾嫓霅橃 鞎婌晿鞀惦媹雼�.
雮措秬鞛� 毵れ垬電� 鞚茧皹鞝侅溂搿� 旮嶌爼鞝侅溂搿� 韽夑皜霅橃毵�, 鞚措矆 瓯半灅 攴滊鈥�55欤缄皜 AUBN鞚� 鞎� 360毵� 欤� 氚滍枆欤检嫕鞐� 牍勴暣鈥旊姅 臧�旃� 韽夑皜雮� 鞙犽彊靹� 旄‰┐鞐愳劀 氙鸽頃╇媹雼�. 攴鸽熂鞐愲弰 攵堦惮頃橁碃 鞚措矆 鞁犼碃電� 鞚�頄� 鞚挫偓須� 彀洂鞚� 歆�靻嶌爜鞚� 鞁犽毳� 雮橅儉雮措姅 氇呺靸侅潣 鞁犿樃毳� 鞝滉车頃╇媹雼�.
Le 2 juillet 2025, David E. Housel, administrateur de Auburn National Bancorporation (AUBN), a d茅pos茅 un formulaire 4 signalant deux achats DRIP/optionnels en esp猫ces d鈥檃ctions ordinaires de la soci茅t茅.
- 38 actions acquises 脿 24,6912 $
- 17 actions acquises 脿 23,2233 $
Les participations directes de Housel sont pass茅es d鈥檈nviron 8 476 脿 8 531 actions, soit une augmentation de 0,6 %, pour un co没t total d鈥檈nviron 1 338 $. Aucun instrument d茅riv茅 n鈥檃 茅t茅 impliqu茅, et aucun plan Rule 10b5-1 n鈥檃 茅t茅 indiqu茅.
Bien que les achats d鈥檌niti茅s soient g茅n茅ralement per莽us positivement, la taille de la transaction鈥�55 actions par rapport aux quelque 3,6 millions d鈥檃ctions en circulation d鈥橝UBN鈥攅st n茅gligeable en termes d鈥櫭﹙aluation ou de liquidit茅. N茅anmoins, ce d茅p么t constitue un signal nominal de confiance continue au niveau du conseil d鈥檃dministration de la banque.
Am 2. Juli 2025 reichte David E. Housel, Direktor der Auburn National Bancorporation (AUBN), ein Formular 4 ein, in dem zwei DRIP-/optionale Bark盲ufe von Stammaktien des Unternehmens gemeldet wurden.
- 38 Aktien zu 24,6912 $ erworben
- 17 Aktien zu 23,2233 $ erworben
Housels direkte Beteiligungen stiegen von gesch盲tzten 8.476 auf 8.531 Aktien, ein Anstieg von 0,6 %, bei einem Gesamtaufwand von etwa 1.338 $. Es waren keine Derivate beteiligt, und es wurde kein Rule-10b5-1-Plan angegeben.
Obwohl Insiderk盲ufe allgemein positiv bewertet werden, ist die Transaktionsgr枚脽e鈥�55 Aktien im Vergleich zu den etwa 3,6 Millionen ausstehenden AUBN-Aktien鈥攁us Bewertungs- oder Liquidit盲tssicht unerheblich. Die Meldung signalisiert dennoch nominal ein anhaltendes Vertrauen auf Vorstandsebene in die Bank.
FAQ
How many AUBN shares did director David Housel purchase on 2 July 2025?
What prices did Housel pay for the newly acquired AUBN shares?
What is David Housel鈥檚 total AUBN share ownership after the transaction?
Was the purchase part of a DRIP or Rule 10b5-1 trading plan?
Were any derivative securities involved in this Form 4 filing?
Is this insider transaction considered material for AUBN investors?
